| Literature DB >> 29893776 |
Rose Miranda1,2, Yolanda W H Penders1,2, Tinne Smets1,2, Luc Deliens1,2,3, Guido Miccinesi4, Tomás Vega Alonso5, Sarah Moreels6, Lieve Van den Block1,2.
Abstract
Background: measuring the quality of primary palliative care for older people with dementia in different countries is important to identify areas where improvements can be made. Objective: using quality indicators (QIs), we systematically investigated the overall quality of primary palliative care for older people with dementia in three different countries. Design/setting: a mortality follow-back survey through nation- and region-wide representative Sentinel Networks of General Practitioners (GPs) in Belgium, Italy and Spain. GPs registered all patient deaths in their practice. We applied a set of nine QIs developed through literature review and expert consensus. Subjects: patients aged 65 or older, who died non-suddenly with mild or severe dementia as judged by GPs (n = 874).Entities:
Mesh:
Year: 2018 PMID: 29893776 PMCID: PMC6201823 DOI: 10.1093/ageing/afy087
Source DB: PubMed Journal: Age Ageing ISSN: 0002-0729 Impact factor: 10.668
The selection of EUROSENTIMELC QIs and the calculation of QI scores
aDenominator: all patients for whom this question was answered (unless otherwise indicated).
Patient characteristics between Belgium, Italy and Spain (n = 874)
| Mild dementia ( | Severe dementia ( | |||||||
|---|---|---|---|---|---|---|---|---|
| Belgium ( | Italy ( | Spain ( | Belgium ( | Italy ( | Spain ( | |||
| Mean age at death [SD] | 86.4 [7.3] | 87.6 [5.7] | 88.9 [6.2] | 0.026a | 85.8 [6.7] | 87.9 [6.7] | 88.5 [4.7] | 0.001a |
| Gender, female | 137 (63.1) | 66 (59.5) | 36 (69.2) | 0.502 | 216 (69.7) | 94 (74.6) | 26 (53.1) | 0.031a |
| Longest place of residence in the last year of lifec | <0.001a | <0.001a | ||||||
| At home | 95 (43.4) | 97 (85.1) | 41 (78.8) | 87 (28.0) | 104 (81.3) | 32 (66.7) | ||
| Care homed | 122 (55.7) | 16 (14.0) | 11 (21.2) | 223 (71.7) | 24 (18.8) | 16 (33.3) | ||
| Main cause of death | 0.009a | 0.080 | ||||||
| Malignancy | 51 (23.3) | 9 (8.1) | 9 (17.3) | 32 (10.3) | 5 (4.0) | 8 (16.3) | ||
| Cardiovascular disease | 53 (24.2) | 44 (39.6) | 13 (25.0) | 59 (19.0) | 34 (27.0) | 6 (12.2) | ||
| Disease of nervous system | 25 (11.4) | 8 (7.2) | 5 (9.6) | 100 (32.2) | 39 (31.0) | 19 (38.8) | ||
| Respiratory disease | 32 (14.6) | 18 (16.2) | 3 (5.8) | 19 (6.1) | 15 (11.9) | 4 (8.2) | ||
| Stroke (CVA) | 23 (16.0) | 17 (13.5) | 6 (30.8) | 43 (13.8) | 11 (8.7) | 3 (6.1) | ||
| Other | 35 (16.0) | 15 (13.5) | 16 (30.8) | 58 (18.6) | 22 (17.5) | 9 (18.4) | ||
Missing cases for mild dementia, gender, n = 5 (BE = 2 | IT = 3); cause of death, n = 3 (IT = 3).
Missing cases for severe dementia, gender, n = 4 (BE = 2 | IT = 2); longest place of residence prior to death, n = 3 (BE = 2 | SP = 1); cause of death, n = 3 (BE = 1 | IT = 2).
SD, standard deviation; CVA, cerebrovascular accident.
aSignificant at the 0.05 probability level.
bP-value was determined by conducting multilevel mixed model analysis to account for the clustering at the level of GPs.
cLongest place of residence in the last year of life: ‘Elsewhere’ reported as missing cases (mild dementia, n: Belgium, 2; Italy, 1; Spain, 0 | severe dementia, n: Belgium, 1; Italy, 0; Spain, 0).
dIncludes care/nursing homes in Belgium and Italy and residential homes in Spain.
Scores of the nine QIs for patients with mild and severe dementia between Belgium, Italy and Spain (n = 874)
| Mild dementia ( | Severe dementia ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Belgium ( | Italy ( | Spain ( | Belgium ( | Italy ( | Spain ( | |||||
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||||
| 95 (44) | 14 (12) | 0.15 (0.06–0.40)a | 25 (50) | 1.67 (0.63–4.46) | 124 (41) | 11 (9) | 0.10 (0.04–0.29)a | 22 (47) | 2.28 (0.76–6.88) | |
| 127 (59) | 54 (48) | 0.26 (0.10–0.65)a | 17 (33) | 0.32 (0.10–1.00) | 123 (41) | 26 (21) | 0.25 (0.08–0.76)a | 9 (20) | 0.26 (0.07–1.01) | |
| 76 (42) | 7 (6) | 0.09 (0.03–0.22)a | 3 (20) | 0.33 (0.08–1.30) | 28 (14) | 0 (0) | NA | 1 (11) | 0.93 (0.10–8.62) | |
| 74 (34) | 13 (12) | 0.21 (0.09–0.47)a | 2 (4) | 0.07 (0.01–0.30)a | 31 (10) | 4 (3) | 0.40 (0.15–1.12) | 2 (4) | 0.52 (0.14–2.03) | |
| 162 (81) | 93 (82) | 0.61 (0.27–1.38) | 39 (85) | 0.99 (0.35–2.81) | 244 (84) | 107 (84) | 0.95 (0.42–2.13) | 42 (88) | 1.03 (0.34–3.14) | |
| 84 (39) | 5 (5) | 0.08 (0.03–0.24)a | 4 (8) | 0.11 (0.04–0.37)a | 111 (36) | 13 (10) | 0.30 (0.15–0.61)a | 4 (8) | 0.21 (0.08–0.55)a | |
| 125 (60) | 20 (20) | 0.17 (0.08–0.38)a | 30 (77) | 2.94 (1.14–7.61) | 185 (62) | 12 (11) | 0.08 (0.03–0.18)a | 29 (73) | 1.83 (0.72–4.67) | |
| 162 (74) | 83 (73) | 1.59 (0.86–2.93) | 32 (64) | 0.82 (0.39–1.69) | 264 (85) | 105 (82) | 1.68 (0.86–3.28) | 34 (72) | 0.61 (0.27–1.39) | |
| 150 (69) | 72 (65) | 0.64 (0.28–1.44) | 32 (62) | 0.55 (0.23–1.33) | 189 (62) | 84 (67) | 0.88 (0.44–1.73) | 27 (56) | 0.49 (0.22–1.09) | |
Missing cases for patients with mild dementia, QI 1, n = 4 (BE = 1 | IT = 1 | SP = 2); QI 2, n = 4 (BE = 2 | IT = 1 | SP = 1); QI 3.1, n = 76 (BE = 39 | SP = 37); QI 3.2, n = 1 (IT = 1); QI 4, n = 25 (BE = 19 | SP = 6); QI 5, n = 7 (BE = 2 | IT = 2 | SP = 3); QI 6, n = 36 (BE = 11 | IT = 13 | SP = 12); QI 7, n = 2 (SP = 2); QI 8, n = 5 (BE = 2 | IT = 3).
Missing cases for patients with severe dementia, QI 1, n = 14 (BE = 10 | IT = 2 | SP = 2); QI 2, n = 13 (BE = 8 | IT = 2 | SP = 3); QI 3.1, n = 155 (BE = 115 | SP = 40); QI 3.2, n = 4 (BE = 2 | IT = 2); QI 4, n = 23 (BE = 22 | SP = 1); QI 5, n = 11 (BE = 7 | IT = 3 | SP = 1); QI 6, n = 34 (BE = 12 | IT = 14 | SP = 8); QI 7, n = 4 (BE = 2 | SP = 2); QI 8, n = 9 (BE = 6 | IT = 2 | SP = 1).
Reference group = Belgium. Accounted for the clustering at the level of GPs and adjusted for age, gender, cause of death, and longest place of residence in the last year of life.
CI, confidence interval; OR, odds ratio; Ref., reference category; NA, not applicable.
aSignificant at the 0.05 probability level.
bExcluded ‘don’t know’ (mild dementia, 132; severe dementia, 282).
cThe topics are diagnosis, course of the disease/prognosis, the approaching end of life, advantages and disadvantages of the treatments, options in terms of end-of-life care.
dRegular hospital wards excluding palliative care units.